Berkeley Communications
HTA in the news
GLP-1s, cancer care are driving higher employer health care costs in 2026
STAT
Companies will foot more of the bill to shield workers from big premiums, deductibles
Read moreNC employers look to smaller PBMs without ‘shenanigans’
North Carolina Health News
With many PBMs receiving scrutiny, smaller startups that bill themselves as more transparent are seeing interest from employers in the state and nationally.
Read moreHow Employers Can Build an Effective GLP-1 Strategy
MedCity News
Here are five guidelines to help employers balance health outcomes and financial responsibility to ensure that GLP-1 coverage is effective, affordable, and aligned with improved health and workforce well-being for employees and their families.
Read moreWhy this Democrat healthcare CEO supports HHS Secretary RFK Jr.
VatorNews’ Culture Religion and Technology Podcast
On the CRT (Culture, Religion and Technology) podcast, produced by our partners WeOverMe and Voz Media, Bambi Francisco talks to Robert Andrews is, CEO and head of The Health Transformation Alliance.
Listen nowBeyond the Scale the Ozempic Effect: Episode 6: The Future of GLP-1 Drugs
Drugwatch Podcast
GLP-1 drugs like Ozempic and Wegovy have reshaped how we treat obesity and diabetes — but what’s on the horizon?
Listen nowHealth Transformation Alliance CEO Robert Andrews on what led him to leave his government role and found the collective
Healthcare Brew
The group of health organizations is trying to “fix our broken healthcare system,” CEO Robert Andrews says.
Read moreThe Myth of All-American Drugs and What Trump’s Tariffs Miss About Pharma Supply Chains
MedCity News
Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S. Untangling the sprawling, global supply chain will be complicated and expensive, and could inadvertently compete with other administration goals.
Read moreBeyond the Scale: The Ozempic Effect: Episode 4- Off-Label Use and Compounded GLP-1 Drugs
Drugwatch Podcast
In Episode 4 of Beyond the Scale: The Ozempic Effect, hosts Terry Turner and Christian Simmons investigate the growing off-label use of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro.
Listen now